SEC 13F Intelligence

Argyle Capital Management, LLC / AMGN

Argyle Capital Management, LLC’s Amgen Inc Position

Does Argyle Capital Management, LLC own Amgen Inc (AMGN)? Yes — 19.4K shares worth $7M (+2.21% of its 13F portfolio) as of Q1 2026.

Position Value
$7M
Q1 2026
Shares
19.4K
% of Portfolio
+2.21%
Quarters Held
30
currently held

Position History AMGN

Reported value by quarter
Q4 ’18: $6MQ4 ’18Q1 ’19: $6MQ2 ’19: $5MQ3 ’19: $6MQ4 ’19: $7MQ4 ’19Q1 ’20: $6MQ2 ’20: $7MQ3 ’20: $7MQ4 ’20: $6MQ4 ’20Q1 ’21: $7MQ2 ’21: $7MQ3 ’21: $6MQ4 ’21: $6MQ4 ’21Q1 ’22: $6MQ2 ’22: $6MQ3 ’22: $6MQ4 ’22: $7MQ4 ’22Q1 ’23: $6MQ2 ’23: $6MQ3 ’23: $7MQ4 ’23: $7MQ4 ’23Q1 ’24: $6MQ2 ’24: $6MQ3 ’24: $6MQ4 ’24: $5MQ4 ’24Q1 ’25: $6MQ2 ’25: $5MQ3 ’25: $5MQ4 ’25: $6MQ4 ’25Q1 ’26: $7Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202619.4K$7M+2.21%
Q4 202519.4K$6M+2.12%
Q3 202519.4K$5M+1.89%
Q2 202519.4K$5M+1.96%
Q1 202519.6K$6M+2.26%
Q4 202419.4K$5M+1.99%
Q3 202419.0K$6M+2.44%
Q2 202419.8K$6M+2.54%
Q1 202421.8K$6M+2.40%
Q4 202322.6K$7M+2.69%
Q3 202325.7K$7M+2.53%
Q2 202325.0K$6M+2.00%
Q1 202326.5K$6M+2.25%
Q4 202226.4K$7M+2.38%
Q3 202226.7K$6M+2.34%
Q2 202226.7K$6M+2.33%
Q1 202226.7K$6M+2.10%
Q4 202127.5K$6M+1.93%
Q3 202128.0K$6M+1.97%
Q2 202128.1K$7M+2.21%
Q1 202127.9K$7M+2.34%
Q4 202027.9K$6M+2.39%
Q3 202028.1K$7M+2.93%
Q2 202028.3K$7M+2.80%
Q1 202028.6K$6M+2.74%
Q4 201928.6K$7M+2.45%
Q3 201929.1K$6M+2.13%
Q2 201929.1K$5M+2.04%
Q1 201929.1K$6M+2.13%
Q4 201829.0K$6M+2.39%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Argyle Capital Management, LLC’s full portfolio or all institutional holders of AMGN.